Literature DB >> 23427402

Effect of lichong decoction on expression of IGF-I and proliferating cell nuclear antigen mRNA in rat model of uterine leiomyoma.

Donghua Li1, Yalan Zhang, Hongjuan Han, Jianguo Geng, Xiaolei Xie, Jiubo Zheng, Yasong Wang, Xiaoli Zou.   

Abstract

OBJECTIVE: To study the effect of Lichong Decoction (Lichong Decoction for strengthening anti-pathogenic Qi and eliminating blood stasis) on the expression of insulin-like growth factor-I (IGF-I) and proliferating cell nuclear antigen (PCNA) mRNA in a rat model of uterine leiomyoma.
METHODS: Fifty female Wistar rats were randomized into a normal control group, model group, Lichong Decoction group, Guizhifuling Capsule (Capsule containing Cassia Twig and Poria) group, and Mifepristone group. The uterine leiomyoma model was established by peritoneal injections of exogenous estrogen and progesterone hormone. The ultrastructural changes in cells of rat uterine tissues were observed with transmission electron microscopy, and the expression of IGF-I and PCNA mRNA was detected by real-time fluorescent quantitative PCR.
RESULTS: Following treatment, cells in the Lichong Decoction group appeared to be arranged normally, the cellular morphology were almost in a normal state, hyperplasia and hypertrophy of the chondriosome was reduced, collagen fibers were arranged in a regular manner, without obvious hyperplasia, and the expression of IGF-I and PCNA mRNA was significantly decreased compared with the model group (P < 0.01).
CONCLUSIONS: The effect of Lichong Decoction on uterine leiomyoma is related to its function in reducing the expression of IGF-I and PCNA mRNA.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23427402     DOI: 10.1016/s0254-6272(13)60084-9

Source DB:  PubMed          Journal:  J Tradit Chin Med        ISSN: 0255-2922            Impact factor:   0.848


  6 in total

1.  Proceedings from the Third National Institutes of Health International Congress on Advances in Uterine Leiomyoma Research: comprehensive review, conference summary and future recommendations.

Authors:  James H Segars; Estella C Parrott; Joan D Nagel; Xiaoxiao Catherine Guo; Xiaohua Gao; Linda S Birnbaum; Vivian W Pinn; Darlene Dixon
Journal:  Hum Reprod Update       Date:  2014-01-08       Impact factor: 15.610

Review 2.  Evidence-Based Management of Uterine Fibroids With Botanical Drugs-A Review.

Authors:  Masita Arip; Vi Lien Yap; Mogana Rajagopal; Malarvili Selvaraja; K Dharmendra; Sasikala Chinnapan
Journal:  Front Pharmacol       Date:  2022-06-22       Impact factor: 5.988

3.  Gyejibongneyong-hwan, a herbal medicine for the treatment of dysmenorrhoea with uterine fibroids: a protocol for a randomised controlled trial.

Authors:  Jeeyoun Jung; Ju Ah Lee; Mi Mi Ko; Sooseong You; Eunhee Lee; Jiae Choi; Byoung-Kab Kang; Myeong Soo Lee
Journal:  BMJ Open       Date:  2016-11-24       Impact factor: 2.692

4.  Establishment of a rat model for uterine leiomyomas based on Western and traditional Chinese medicine theories.

Authors:  Hui Zhao; Yao Li; QiuXia Xu; Fu Peng; JinShuang Zhao; R Clinton Webb; Cheng Peng; ChengHao Yu
Journal:  Braz J Med Biol Res       Date:  2018-07-02       Impact factor: 2.590

5.  The levels of follicular fluid cell-free mitochondrial DNA could serve as a biomarker for pregnancy success in patients with small ovarian endometriosis cysts: A case-control study.

Authors:  Ping Huo; Ning Zhang; Pingping Zhang; Xiaohua Wu
Journal:  Medicine (Baltimore)       Date:  2020-11-25       Impact factor: 1.889

6.  Geijigajakyak decoction inhibits the motility and tumorigenesis of colorectal cancer cells.

Authors:  Soong-In Lee; Jeong A Bae; Yoo-Seung Ko; Kyoung-In Lee; Hangun Kim; Kyung Keun Kim
Journal:  BMC Complement Altern Med       Date:  2016-08-15       Impact factor: 3.659

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.